Rate My Professor Morna Dorsey

Morna Dorsey, MD, MS, holds the Kathryn Grupe Endowed Chair and serves as Professor of Pediatrics in the Department of Pediatrics at the University of California, San Francisco School of Medicine. She is the Director of the Pediatric Allergy and Immunology Program and Medical Director of the Pediatric Immunology and Allergy Center at UCSF Benioff Children's Hospitals. Additionally, she directs the Allergy and Immunology Fellowship program and co-directs UCSF's newborn screening program for severe combined immunodeficiency (SCID). Board-certified in Allergy and Immunology and Pediatrics, Dr. Dorsey completed her fellowship in allergy and immunology at Boston Children's Hospital, the pediatric teaching hospital of Harvard Medical School. With over 25 years of clinical experience, she specializes in pediatric allergy and immunology, focusing on primary immunodeficiencies, hematopoietic stem cell transplantation, food allergies, and eosinophilic disorders.

Dr. Dorsey's research centers on three key areas: optimizing diagnosis and care for patients with primary immunodeficiency, investigating the psychosocial impact of these conditions on patients and families, and developing treatments for food allergy and eosinophilic disorders. She is principal investigator on the California SCID Consortium Long-term Follow-up Program and co-investigator on NIH-funded projects for rare genetic immune diseases. Her influential publications include 'Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC' (Blood Advances, 2026), 'Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency' (Journal of Clinical Immunology, 2025), 'Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy' (New England Journal of Medicine, 2023), and 'Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening' (Journal of Allergy and Clinical Immunology, 2017). Through her leadership in the Primary Immune Deficiency Treatment Consortium (PIDTC), Dr. Dorsey has advanced newborn screening protocols, improved transplantation outcomes, and enhanced long-term care for immunodeficient children, significantly impacting clinical practice and patient survival rates in the field.